GET3
ATPase GET3
Also known as: ARSA-I, ASNA1, GET3_HUMAN, TRC40
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43681
- Gene
- GET3
- Ensembl
- ENSG00000198356
- Chromosome
- 19
- Canonical length
- 348 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Nucleoli
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene represents the human homolog of the bacterial arsA gene, encoding the arsenite-stimulated ATPase component of the arsenite transporter responsible for resistance to arsenicals. This protein is also a central component of a transmembrane domain (TMD) recognition complex (TRC) that is involved in the post-translational delivery of tail-anchored (TA) proteins from the cytosol to the endoplasmic reticulum (ER). It recognizes and selectively binds the TMD of TA proteins in the cytosol, and delivers them to the ER for insertion. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
348 residues, UniProt reviewed canonical sequence.
>O43681|GET3
1 MAAGVAGWGV EAEEFEDAPD VEPLEPTLSN IIEQRSLKWI FVGGKGGVGK TTCSCSLAVQ
61 LSKGRESVLI ISTDPAHNIS DAFDQKFSKV PTKVKGYDNL FAMEIDPSLG VAELPDEFFE
121 EDNMLSMGKK MMQEAMSAFP GIDEAMSYAE VMRLVKGMNF SVVVFDTAPT GHTLRLLNFP
181 TIVERGLGRL MQIKNQISPF ISQMCNMLGL GDMNADQLAS KLEETLPVIR SVSEQFKDPE
241 QTTFICVCIA EFLSLYETER LIQELAKCKI DTHNIIVNQL VFPDPEKPCK MCEARHKIQA
301 KYLDQMEDLY EDFHIVKLPL LPHEVRGADK VNTFSALLLE PYKPPSAQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GET3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 85 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 85 nTPM
- cerebral cortex: 72 nTPM
- kidney: 71 nTPM
- parathyroid gland: 69 nTPM
- heart muscle: 69 nTPM
- skeletal muscle: 68 nTPM
Single-cell type
- late spermatids: 293 nCPM
- esophageal apical cells: 196 nCPM
- oocytes: 193 nCPM
- esophageal suprabasal cells: 191 nCPM
- hofbauer cells: 177 nCPM
- decidual stromal cells: 166 nCPM
Immune cell
- myeloid DC: 45 nTPM
- classical monocyte: 44 nTPM
- non-classical monocyte: 43 nTPM
- total PBMC: 36 nTPM
- intermediate monocyte: 34 nTPM
- T-reg: 34 nTPM
Brain region
- choroid plexus: 64 nTPM
- cerebral cortex: 57 nTPM
- cerebellum: 57 nTPM
- thalamus: 56 nTPM
- hypothalamus: 56 nTPM
- pons: 54 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GET3.
Disease | AllUniProt
Conditions GET3 is implicated in, by any mechanism.
- Cardiomyopathy, dilated, 2H (CMD2H) MIM:620203
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 46 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cardiomyopathy, dilated, 2H
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.35
- gnomAD pLI
- 0.94
- DepMap mean gene effect
- -0.64
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-loop containing nucleoside triphosphate hydrolase
- Arsenical pump ATPase, ArsA/GET3
- ArsA/GET3, Anion-transporting ATPase-like domain
- Arsenical pump ATPase, ArsA/GET3, eukaryotic
- Anion-transporting ATPase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GET3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GET3 as an antibody target. Whether an autoantibody or antibody against GET3 could matter depends on whether native GET3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GET3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GET3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...